OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
The gut microbiome is a critical mediator in the interaction between an individual and their nutritional environment. As such, it has great potential as a target for the prevention and treatment of diet-related metabolic diseases.
This talk reports recent large-scale, multi-omic studies of the gut microbiome in type 2 diabetes and non-alcoholic fatty liver disease. In doing so, it addresses the role of microbially-mediated inflammation in the onset and development of both diseases. It also highlights the challenges inherent in microbiome studies, where causality may be attributed at the level of a single species, a clade, or a complex community.
